API
< Back to situation

[REVISION HISTORY]

COPD diagnosis and treatment developments

2 recorded revisions of this situation.

What changed

2026-11-18 15:18 UTC → 2026-11-18 21:47 UTC · added removed

Medical experts are emphasizing the critical need for early diagnosis of chronic obstructive pulmonary disease (COPD) to improve patient outcomes. Research is currently exploring anti-alarmin therapies, such as itepekimab and astegolimab, to manage disease exacerbations driven by pollutants, bacteria, or viruses. In Spain, health professionals and patient associations are specifically calling for improved detection, noting that approximately 75 percent of cases remain undiagnosed. Local initiatives, such as those in Fuerteventura, have implemented free screening tests and awareness programs to encourage smokers and former smokers to seek medical evaluation. During World COPD Day observations, the global scale of the issue was highlighted, noting that COPD is the third leading cause of death, claiming over 3 million lives annually. While Spain faces a 75 percent underdiagnosis rate, Italy reports that an estimated 70 percent of cases are diagnosed with significant delays. New data from 2026 indicates that Canada faces a similarly high undiagnosed rate of roughly 80 percent. Medical professionals warn that symptoms like persistent cough, shortness of breath, and frequent phlegm are often mistakenly attributed to aging. Risk factors include tobacco use, air pollution, biomass smoke, and occupational exposure to chemicals or dust. Experts stress that early diagnosis through spirometry is and the use of respiratory physiotherapy are vital to preserving lung function. function and patient autonomy. Treatment options are expanding. In Spain, the public health system has approved funding for biological treatments, specifically dupilumab and mepolizumab. These therapies target specific inflammatory mechanisms and are expected to benefit approximately 25,000 patients who experience frequent exacerbations despite standard inhaled therapies. Beyond physical symptoms, experts note that the disease can impact mental health, contributing to anxiety and social isolation.

Versions

  1. 2026-11-18 21:47 UTC COPD diagnosis and treatment developments
  2. 2026-11-18 15:18 UTC COPD diagnosis and treatment developments
  3. 2026-11-17 13:58 UTC COPD diagnosis and treatment developments

Select a version to see what changed compared to the one before it.